The Role of Galectins in Cervical Cancer Biology and Progression

被引:56
|
作者
Wang, Lufang [1 ]
Zhao, Yanyan [1 ]
Wang, Yanshi [1 ]
Wu, Xin [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Liaoning, Peoples R China
关键词
SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; CD8(+) T-CELLS; UP-REGULATION; TUMOR-GROWTH; H-RAS; PHOSPHOINOSITIDE; 3-KINASE; ANTIANGIOGENESIS THERAPY; BINDING-PROTEIN; DENDRITIC CELLS;
D O I
10.1155/2018/2175927
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cervical cancer is one of the malignant tumors with high incidence and high mortality among women in developing countries. The main factors affecting the prognosis of cervical cancer are the late recurrence and metastasis and the effective adjuvant treatment, which is radiation and chemotherapy or combination therapy. Galectins, a family containing many carbohydrate binding proteins, are closely involved in the occurrence and development of tumor. They are involved in tumor cells transformation, angiogenesis, metastasis, immune escape, and sensitivity against radiation and chemotherapy. Therefore, galectins are deemed as the targets of multifunctional cancer treatment. In this review, we mainly focus on the role of galectins, especially galectin-1, galectin-3, galectin-7, and galectin-9 in cervical cancer, and provide theoretical basis for potential targeted treatment of cervical cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Molecular profiling of cervical cancer progression
    T Hagemann
    T Bozanovic
    S Hooper
    A Ljubic
    V I F Slettenaar
    J L Wilson
    N Singh
    S A Gayther
    J H Shepherd
    P O A Van Trappen
    British Journal of Cancer, 2007, 96 : 321 - 328
  • [42] Molecular profiling of cervical cancer progression
    Hagemann, T.
    Bozanovic, T.
    Hooper, S.
    Ljubic, A.
    Slettenaar, V. I. F.
    Wilson, J. L.
    Singh, N.
    Gayther, S. A.
    Shepherd, J. H.
    Van Trappen, P. O. A.
    BRITISH JOURNAL OF CANCER, 2007, 96 (02) : 321 - 328
  • [43] The progression of genomic instability in cervical cancer
    Diaz-Arrastia, C. R.
    Botting, S.
    Khatoon, N.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S147 - S147
  • [44] Refining insight into cervical cancer progression
    Sakuragi, Noriaki
    LANCET ONCOLOGY, 2014, 15 (04): : 371 - 372
  • [45] Molecular determinants of cervical cancer progression
    不详
    ANTICANCER RESEARCH, 2004, 24 (06) : 4267 - 4267
  • [46] Genetic pathways in cervical cancer progression
    不详
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 30 - 30
  • [47] Galectins and Ovarian Cancer
    Shimada, Chisa
    Xu, Rui
    Al-Alem, Linah
    Stasenko, Marina
    Spriggs, David R.
    Rueda, Bo R.
    CANCERS, 2020, 12 (06)
  • [48] The sweet and bitter sides of galectins in melanoma progression
    Braeuer, Russell R.
    Shoshan, Einav
    Kamiya, Takafumi
    Bar-Eli, Menashe
    PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (05) : 592 - 601
  • [49] A review on the role of epidermal growth factor signaling in the development, progression and treatment of cervical cancer
    Muthusami, Sridhar
    Sabanayagam, Rajalakshmi
    Periyasamy, Loganayaki
    Muruganantham, Bharathi
    Park, Woo Yoon
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 194 : 179 - 187
  • [50] The Mclust Analysis of Tumor Budding Unveils the Role of the Collagen Family in Cervical Cancer Progression
    Lee, Olive E. M.
    Le, Tan Minh
    Chong, Gun Oh
    Cho, Junghwan Joshua
    Park, Nora Jee-Young
    LIFE-BASEL, 2024, 14 (08):